Navigation Links
Despite recession, children's health spending increased between 2009-2012, says new report
Date:2/26/2014

Washington, DC Spending on health care for children covered by employer-sponsored insurance (ESI) increased between 2009 and 2012, rising an average 5.5 percent a year, with more dollars spent on boys than girls, and higher spending on infants and toddlers (ages 0-3) than any other children's age group, finds a new report released today by the Health Care Cost Institute (HCCI). Per capita spending on children reached $2,437 in 2012, a $363 increase from 2009. The study shows a growth in prescription use by children through age 18, as well as a rise in the number of teens being admitted for mental health and substance use (MHSU) treatment.

The report, Children's Health Spending: 2009-2012, presents the most up-to-date data on health care spending trends for privately insured children under age 19. It is based on fee-for-service claims for 10.5 million children per year who were covered by employer-sponsored health insurance (ESI). For all years studied, HCCI found rising prices contributed more to spending growth than did utilization of services. However, increased prescription use contributed to rising spending for children over the age of 3.

Big Gender Gap in Spending

Until age 14, boys had higher health care spending than girls, and boys of all ages had a higher share of spending on brand prescriptions. In 2012, spending for boys reached $2,572, while spending on girls was $2,296 a $276 gender difference. Out-of-pocket spending also was higher for boys than for girls, $440 per boy and $414 per girl. When children reached their teens, spending on health care for girls was higher than boys, a trend that continues throughout adulthood until about age 60.

Rise in Prescription Use and Teen Mental Health Admissions

All age groups saw increased overall prescription spending in 2011 and 2012, according to the report. The most common prescription drug class was central nervous system (CNS) agents (commonly associated with attention deficit hyperactivity disorder, anxiety, and depression). Use of CNS drugs by younger children (ages 4-8), pre-teens (ages 9-13), and teens (ages 14-18) rose over time, and in each age group boys had higher use of CNS drugs than girls. Between 2011 and 2012, younger children, pre-teens, and teenagers saw double-digit growth in generic CNS use.

Teen girls had higher levels of overall prescription use than teen boys. In 2012, teen boys used an average 89 filled days of brand and generic prescriptions; in contrast, teen girls averaged 128 filled days. The difference in prescription usage between boys and girls was largely a result of teen girls' use of synthetic hormones (typically associated with birth control pills).

"The trend of rising use of prescriptions among children is particularly notable," says HCCI Executive Director David Newman. "We, and others, need to focus on the mental health needs of our children."

Other report highlights:

  • Infants and Toddlers: For infants and toddlers, per child spending was $4,446 in 2012, and was largely driven by visits to doctors' offices and hospital care for the sickest newborns. Hospitalizations accounted for nearly 40% of spending per baby.

  • Younger Children and Pre-Teens: Possibly triggered by the recession, health care spending growth dipped temporarily in 2010, due in large part to decreased use of health care services. In 2010, outpatient visits to emergency rooms declined for all children, with the most pronounced declines for younger children and pre-teens.

  • Teen Use of Mental Health and Substance Use (MHSU) Services Grew: There was rising use of mental health services by teens, and there were more MHSU admissions for girls than for boys in all years studied. For girls, use rose from 9 admits per 1,000 teen girls in 2010 to 11 in 2012; for boys, MHSU admits rose from 7 per 1,000 teen boys in 2010 to 9 in 2012.

  • Out-of-Pocket Spending Rose: Slightly more than 17 percent of health care spending per child was paid out of pocket between 2009 and 2012, with out-of-pocket spending growing fastest in the Midwest and the South.

  • Prescription Spending Growth: In 2012, spending on prescriptions for children rose 7.1 percent, 2.1 percentage points faster than in 2011, and 2.3 percentage points faster than in 2010. Higher prescription expenditure growth was driven mainly by rising use of generics.

  • Spike in Meningitis Vaccines Among Teens: Federal policies may have helped prompt a 47.6 percent spike in meningitis vaccination rates among teens in 2011, and an additional 16.4 percent increase in 2012. These increases were likely due to vaccine recommendations promulgated by the Centers for Disease Control and Prevention and benefit changes under the Affordable Care Act.

"We hope this report illustrates where health care spending for children is occurring," says HCCI Senior Researcher Amanda Frost. "While we know that prices have fueled health care spending growth, this report shows where those dollars are going to help identify implications for children's health and care."

The Children's Health Spending: 2009-2012 will be available on the Health Care Cost Institute's website on February 27, 2014 at 12:01 a.m. ET at: http://www.healthcostinstitute.org/childrens-health-spending-2009-2012.


'/>"/>

Contact: Maya Brod
mbrod@burnesscommunications.com
301-280-5757
Burness Communications
Source:Eurekalert

Related medicine news :

1. Many Still Tanning, Despite Dangers, Survey Finds
2. Despite less play, childrens use of imagination increases over 2 decades
3. Despite hardships, black men in urban communities are resilient, MU researcher says
4. Despite clear benefits, heart failure clinics are rarely utilized
5. Seniors Creativity Can Thrive Despite Dementia
6. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
7. Ethnic disparities in breast cancer survival remain despite socioeconomic similarities
8. Pneumonia remains the leading killer of children despite decline in global child deaths
9. Despite FDA Warning, Sports Supplements Still Available Online: Study
10. Despite hype, costly prostate cancer treatment offers little relief from side effects
11. Many U.S. Teens at Risk for Suicide Despite Treatment: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 21, 2017 , ... Caronlab Australia, an Australian company known for health and ... Hilton Head, SC, where it benefited from outstanding meetings with major retail buyers. , ... wellness products. At this trade show, the company had the chance to demonstrate its ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s ... electrifying line-up of events for its annual meeting “Coming Home 2017,” an activity-packed ... “Coming Home 2017” will be held on Friday January 27 through Sunday, January ...
(Date:1/20/2017)... ... ... ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is easy ... wheeled out of the way and stored when not in use. It is freestanding and ... from customers into specific enhancements and created a new product that is built directly on ...
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional supplements for ... Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its entire line ... all clients at reasonable prices. At the ECRM trade show, it had a unique ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Report Details What can ... are going to grow at the fastest rates? This ... data, trends, opportunities and prospects. Our 190-page report ... lucrative areas in the industry and the future market ... across the all the major categories of the ophthalmic ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
Breaking Medicine Technology: